Gene · 683
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Supplementation with NAD+ and Its Precursors to Prevent Cognitive Decline across Disease Contexts. | Nutrients | 2022 | 35956406 | PubTator, text mining | PubMed |
| NAD+ and its possible role in gut microbiota: Insights on the mechanisms by which gut microbes influence host metabolism. | Anim Nutr | 2022 | 35949199 | PubTator, text mining | PubMed |
| Severe aplastic anaemia after serial vaccinations for SARS-CoV-2, pneumococcus and seasonal influenza. | EJHaem | 2022 | 35941884 | PubTator, text mining | PubMed |
| Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease. | NPJ Parkinsons Dis | 2022 | 35931783 | PubTator, text mining | PubMed |
| Compartmentalized regulation of NAD+ by Di (2-ethyl-hexyl) phthalate induces DNA damage in placental trophoblast. | Redox Biol | 2022 | 35926314 | PubTator, text mining | PubMed |
| The Protein-Protein Interaction Network of Hereditary Parkinsonism Genes Is a Hierarchical Scale-Free Network. | Yonsei Med J | 2022 | 35914754 | PubTator, text mining | PubMed |
| Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors. | Pharmaceuticals (Basel) | 2022 | 35890155 | PubTator, text mining | PubMed |
| Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery. | Pharmaceuticals (Basel) | 2022 | 35890147 | PubTator, text mining | PubMed |
| Association of circulating gene expression signatures with stiffness following total knee arthroplasty for osteoarthritis: a pilot study. | Sci Rep | 2022 | 35879399 | PubTator, text mining | PubMed |
| A large-scale polygenic risk score analysis identified candidate proteins associated with anxiety, depression and neuroticism. | Mol Brain | 2022 | 35870967 | PubTator, text mining | PubMed |
| TIR-catalyzed ADP-ribosylation reactions produce signaling molecules for plant immunity. | Science | 2022 | 35857644 | PubTator, text mining | PubMed |
| CD38: An important regulator of T cell function. | Biomed Pharmacother | 2022 | 35834988 | PubTator, text mining | PubMed |
| Why is endothelial resilience key to maintain cardiac health? | Basic Res Cardiol | 2022 | 35834003 | PubTator, text mining | PubMed |
| Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan. | J Clin Med | 2022 | 35806906 | PubTator, text mining | PubMed |
| Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. | J Cardiovasc Aging | 2022 | 35801078 | PubTator, text mining | PubMed |
| Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis. | Kidney Int | 2022 | 35788359 | PubTator, text mining | PubMed |
| Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway. | Front Pharmacol | 2022 | 35784691 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction in cell senescence and aging. | J Clin Invest | 2022 | 35775483 | PubTator, text mining | PubMed |
| Distinct developmental and degenerative functions of SARM1 require NAD+ hydrolase activity. | PLoS Genet | 2022 | 35737728 | PubTator, text mining | PubMed |
| Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease. | Aging Cell | 2022 | 35730144 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/683/papers?page=11